The Roche Group is the world's leading provider of cancer care products. Our anti-cancer medicines are saving lives and significantly advancing the way some cancers are treated. In addition, Roche is developing new diagnostic tests that will have a significant impact on disease management for cancer patients in the future. With a broad portfolio of tumour markers as well as a range of molecular oncology tests, Roche will continue to be one of the leaders in providing cancer-focused treatments and diagnostics.